Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

P&G develops dihydrobenzofuran compounds for inflammation

Oct. 17, 1997

COX-2 inhibitors from Chugai

Oct. 17, 1997

New antiarthritic agents described by Procter & Gamble

Oct. 15, 1997

Verigen licenses Italian rights to anti-TNF-alpha product

Oct. 14, 1997

Eltenac efficacy demonstrated in osteoarthritis

Oct. 13, 1997

FDA grant awarded for research on Dupuytren's disease therapy

Oct. 8, 1997

Clinical pharmacokinetic profile of rhIL-10

Oct. 8, 1997

Celgene initiates clinical trials for novel TNF-alpha inhibitors

Oct. 6, 1997

BB-2983 development discontinued

Oct. 6, 1997

Wyeth-Ayerst to promote Immunex's ENBREL in U.S.

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...